June 2026
The global vascular grafts market size is evaluated at USD 6.29 billion in 2025 and is projected to hit around USD 10.33 billion by 2035 with a notable CAGR of 5.09%.
August 2026
The global cardiovascular devices market size is expected to increase from USD 74.71 billion in 2025 to hit around USD 158.41 billion by 2035, with a CAGR of 7.81%.
July 2026
The global cardiovascular ultrasound market size reached USD 3.01 billion in 2025 and is projected to surpass around USD 5.61 billion by 2035 with a CAGR of 6.42%.
July 2026
The global bone grafts and substitutes market size was estimated at USD 3.38 billion in 2025 and is expected to hit around USD 5.99 billion by 2035, growing at a CAGR of 5.89%.
July 2026
The global dental bone grafts substitutes market size is expected to hit around USD 2,352.90 million by 2035 from USD 974.86 million in 2025 with a CAGR of 9.21%.
July 2026
The global cardiovascular drugs market size is valued at USD 155.96 billion in 2025 and is expected to hit around USD 221.20 billion by 2035, growing at a CAGR of 3.56% from 2026 to 2035.
July 2026
Discover how the next gen cardiovascular treatments market is revolutionizing cardiac care through smart devices, gene therapy, and AI.
June 2026
The global neurovascular thrombectomy devices market size is anticipated at USD 825.92 million in 2025 and is predicted to hit around USD 1,585.54 million by 2035, growing at a CAGR of 6.74%.
June 2026
The US bone grafts and substitutes market size was evaluated at USD 1.31 billion in 2025 and is predicted to hit around USD 2.25 billion by 2035, growing at a CAGR of 5.56%.
June 2026
The US cardiovascular drugs market size was evaluated at USD 28.42 billion in 2025 and is predicted to hit around USD 37.03 billion by 2035, growing at a CAGR of 2.68%.
June 2026
The global 3D bioengineered skin grafts market is surging, with an overall revenue growth expectation of hundreds of millions of dollars from 2026 to 2035.
May 2026
The global intravascular lithotripsy market size was evaluated at USD 1.07 billion in 2025 and is predicted to hit around USD 4.41 billion by 2035, growing at a CAGR of 15.21%.
April 2026
The global neurovascular embolization devices market size is estimated to hit around USD 4.58 billion by 2035 increasing from USD 1.5 billion in 2025, with a CAGR of 11.80%.
March 2026
The global interventional cardiology and peripheral vascular device market size is expected to increase from USD 27.96 billion in 2025 to hit around USD 63.80 billion by 2035, growing at a CAGR of 8.60%.
February 2026
The global aortic stent grafts market size was evaluated at USD 4.10 billion in 2025 and is predicted to hit around USD 8.57 billion by 2035, growing at a CAGR of 7.65%.
February 2026
The cardiovascular digital solutions market size is expected to hit around USD 212.53 billion by 2035 from USD 128.41 billion in 2025 with a CAGR of 5.17%.
February 2026
The global cardiovascular genetic testing market size was evaluated at USD 11.34 billion in 2025 and is predicted to hit around USD 33.38 billion by 2035, growing at a CAGR of 11.4%.
January 2026
The neurovascular catheters market size accounted for USD 6.37 billion in 2025 and it is expected to hit around USD 13.20 billion by 2035 with a CAGR of 7.56%.
December 2025
The neurovascular devices market size is calculated at USD 3.27 billion in 2025 and is projected to hit around USD 7.12 billion by 2035 with a CAGR of 8.20%.
August 2025
The global intravascular imaging market size reached USD 411.37 million in 2024 and is projected to surpass around USD 697.37 million by 2034, with a notable CAGR of 5.42%.
July 2025
The global stromal vascular fraction market size is estimated to hit around USD 5.02 billion by 2034 increasing from USD 1.54 billion in 2024, with a CAGR of 12.54%.
July 2025
The global vascular access devices market size is projected to attain around USD 3.36 billion by 2034 from USD 2.02 billion in 2024, with a solid CAGR of 5.22%.
July 2025
The global cardiovascular clinical trials market size was valued at USD 5.94 billion in 2024 and is expected to hit around USD 10.62 billion by 2034, growing at a CAGR of 5.98%.
June 2025
The global cardiovascular health supplements market size reached USD 12.04 billion in 2024 and is projected to surpass around USD 25.83 billion by 2034 with a CAGR of 7.93%.
June 2025
The vascular closure devices market size was valued at USD 1.58 billion in 2024 and is expected to surpass around USD 2.76 billion by 2034, with a CAGR of 5.73%.
July 2026
The global lipid-lowering drugs market size was evaluated at USD 35.46 billion in 2025 and is projected to attain around USD 49.65 billion by 2035 with a CAGR of 3.42%.
July 2025
The global artificial blood vessels market size reached USD 2.23 billion in 2024, and is projected to surpass around USD 3.75 billion by 2034 with a notable CAGR of 5.33%.
July 2025
The global fibrate drugs market size was valued at USD 3.42 billion in 2024 and is projected to attain around USD 5.67 billion by 2034 with a CAGR of 5.19%.
July 2025
The global PCSK9-targeted therapy market size is estimated to hit around USD 28.71 billion by 2034 increasing from USD 10.54 billion in 2024, with a CAGR of 10.54%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com